Althea Stillman
Director/Miembro de la Junta en Innervace, Inc. .
Cargos activos de Althea Stillman
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Innervace, Inc.
 Innervace, Inc. BiotechnologyHealth Technology Innervace, Inc. is an American regenerative therapy company that develops technology to replace lost connections due to brain degeneration or injury. The company is based in Philadelphia, PA. The company's lead program focuses on mimicking the lost nigrostriatal pathway in patients with Parkinson's disease. The company was founded by Kacy Cullen and Douglas Smith, and the CEO is Nader Halim. | Director/Miembro de la Junta | - | - |
Historial de carrera de Althea Stillman
Antiguos cargos conocidos de Althea Stillman.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Director/Miembro de la Junta | - | - |
Formación de Althea Stillman.
| University of California, Berkeley | Undergraduate Degree |
| Yale University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
Innervace, Inc.
Innervace, Inc. BiotechnologyHealth Technology Innervace, Inc. is an American regenerative therapy company that develops technology to replace lost connections due to brain degeneration or injury. The company is based in Philadelphia, PA. The company's lead program focuses on mimicking the lost nigrostriatal pathway in patients with Parkinson's disease. The company was founded by Kacy Cullen and Douglas Smith, and the CEO is Nader Halim. | Health Technology |
- Bolsa de valores
- Insiders
- Althea Stillman
- Experiencia
